During the past decade, Henry Ford Hospital Transplant Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Henry Ford Hospital Transplant Institute" are "Kidney Transplantation" (2 trials), "Chronic Kidney Failure" (1 trials), "Kidney Diseases" (1 trials), "Pulmonary Embolism" (1 trials) and "Renal Transplantation" (1 trials). Many other conditions were trialed in "Henry Ford Hospital Transplant Institute" in a lesser frequency.

Most popular intervention types in "Henry Ford Hospital Transplant Institute" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "AEB071" (1 trials), "Apixaban" (1 trials), "Belatacept LI (less intensive)" (1 trials), "Belatacept Less Intensive Regimen (LI)" (1 trials) and "Belatacept MI (more intensive)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Henry Ford Hospital Transplant Institute" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Henry Ford Hospital Transplant Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Henry Ford Hospital Transplant Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Henry Ford Hospital Transplant Institute, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".